home / stock / cpmd / cpmd articles
As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders...
$30 Million in Revenues Projected over 12 Months CannaPharmaRx ( OTCMKTS: CPMD ) announced on December 22nd, 2022, that Health Canada has awarded a...
Over the past twenty days of trading, CannaPharmaRx Inc (OTCMKTS: CPMD), from November 14, 2022 to December 20, 2022 there is a potential Short Squ...
News, Short Squeeze, Breakout and More Instantly...
CALGARY, AB / ACCESSWIRE / April 2, 2024 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has extinguished convertible notes on the company. This transaction will avoid potential dilution of the company...
CannapharmaRx products have been approved for sale in multiple countries worldwide CALGARY, AB / ACCESSWIRE / March 14, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received its first p...
CALGARY, AB / ACCESSWIRE / March 12, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has completed its first five grows and harvests that are ready for sale. Samples of the newer grows have been s...